News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Waverx Goes Under After FDA-Weary Investors Pull the Plug


8/22/2011 8:08:13 AM

WaveRx Inc.'s head slipped under the water forever, a victim of its backers' doubts about the FDA ever giving a green light to its technology for treating diabetic neuropathy. Mark Wan, a founding partner at Three Arch Partners, told the VentureWire blog that his VC company and its two other partners in WaveRx, 5AM Ventures and Polaris Venture Partners, shut the taps last year after waiting for an answer from the FDA's Center for Devices & Biological Health about its proposal for a re-vamped clinical trial.

Read at Xconomy
Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES